Buy Rating Affirmed for Tenet Healthcare on Strong Financials and Growth Prospects
Raymond James Maintains Jones Lang LaSalle(JLL.US) With Buy Rating, Raises Target Price to $268
Tenet Healthcare Price Target Raised to $168.00/Share From $112.00 by Cantor Fitzgerald
Tenet Healthcare Analyst Ratings
Jones Lang Lasalle Price Target Raised to $240.00/Share From $200.00 by Keefe, Bruyette & Woods
Jones Lang LaSalle Analyst Ratings
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $170
Truist Raises Price Target on Tenet Healthcare to $170 From $155, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Tenet Healthcare (THC)
Citi Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $171
Tenet Healthcare (THC) Receives a Buy From Citi
Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating
Tenet Healthcare's Strong Q2 Performance and Upward Guidance Justify Buy Rating
Citigroup Adjusts Reinsurance Group of America Price Target to $252 From $194, Maintains Buy Rating
Reinsurance Group Price Target Raised to $252.00/Share From $194.00 by Citigroup
Reinsurance Gr Analyst Ratings
Scotiabank Maintains W.P. Carey Inc(WPC.US) With Hold Rating, Raises Target Price to $61
Citi Maintains Reinsurance Group of America(RGA.US) With Buy Rating, Raises Target Price to $252
Analysts' Opinions Are Mixed on These Consumer Goods Stocks: Oatly Group (OTLY) and Performance Food Group (PFGC)
Wells Fargo Reaffirms Their Buy Rating on US Foods Holding (USFD)